Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD
- PMID: 9581851
Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD
Abstract
An important early event in the differentiation of skeletal muscle cells is exit from the cell cycle, after which full expression of the muscle phenotype occurs. Rhabdomyosarcoma (RMS), a tumor of skeletal muscle origin, expresses a number of muscle-specific proteins, including MyoD; however, these cells fail to arrest or differentiate when cultured in differentiation medium (DM). To determine the basis for the failure of RMS cells to differentiate or arrest, we studied the molecular response of the embryonal RMS cell line, RD, to culture in DM. Under these conditions, the retinoblastoma protein (RB) was primarily in the hyperphosphorylated state. This is in contrast to myoblasts cultured in DM, in which the hypophosphorylated form of RB is exclusively present. Measurements of the expression and activities of cyclin-dependent kinases (cdks) cdk2 and cdk4 indicated that RD cells maintained higher levels than do myoblasts, and the activity and abundance of these proteins did not significantly decrease upon culture in DM in RD cells, as they did in myoblasts. Similarly, elevated expression of cyclins D1, E, and A was observed in RD cells. Interestingly, cdk inhibitors are expressed in RD cells, with p16ink4 expression markedly elevated relative to myoblasts. Ectopic expression of p21cip1, p16ink4, or p27kip1 caused a growth arrest of RD cells but not detectable expression of a myogenic marker. Furthermore, a constitutively active RB protein could also inhibit the growth of RD cells without inducing myogenic differentiation. Taken together, these data suggest that the elevated levels of cdk2 and/or cdk4 observed in RD cells contribute to the inability of RD cells to growth arrest when cultured in DM but that these activities alone are not responsible for the failure of RD cells to differentiate.
Similar articles
-
p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.Mol Cancer. 2005 Dec 13;4:41. doi: 10.1186/1476-4598-4-41. Mol Cancer. 2005. PMID: 16351709 Free PMC article.
-
Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.Cell Growth Differ. 1998 Sep;9(9):699-711. Cell Growth Differ. 1998. PMID: 9751114
-
Myostatin inhibits rhabdomyosarcoma cell proliferation through an Rb-independent pathway.Oncogene. 2004 Jan 15;23(2):524-34. doi: 10.1038/sj.onc.1207144. Oncogene. 2004. PMID: 14724580
-
Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts.Cell Mol Life Sci. 2001 Apr;58(4):571-9. doi: 10.1007/PL00000882. Cell Mol Life Sci. 2001. PMID: 11361092 Free PMC article. Review.
-
Regulation of MyoD function in the dividing myoblast.FEBS Lett. 2001 Feb 16;490(3):171-8. doi: 10.1016/s0014-5793(01)02120-2. FEBS Lett. 2001. PMID: 11223032 Review.
Cited by
-
p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.Mol Cancer. 2005 Dec 13;4:41. doi: 10.1186/1476-4598-4-41. Mol Cancer. 2005. PMID: 16351709 Free PMC article.
-
Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario.Pharmaceutics. 2023 Feb 16;15(2):664. doi: 10.3390/pharmaceutics15020664. Pharmaceutics. 2023. PMID: 36839989 Free PMC article. Review.
-
TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells.Int J Cancer. 2014 Aug 15;135(4):785-97. doi: 10.1002/ijc.28721. Epub 2014 Jan 27. Int J Cancer. 2014. PMID: 24470334 Free PMC article.
-
Delineation of the androgen-regulated signaling pathways in prostate cancer facilitates the development of novel therapeutic approaches.Curr Opin Pharmacol. 2018 Aug;41:1-11. doi: 10.1016/j.coph.2018.03.002. Epub 2018 Mar 30. Curr Opin Pharmacol. 2018. PMID: 29609138 Free PMC article. Review.
-
CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells.Int J Cancer. 2012 Aug 15;131(4):E437-48. doi: 10.1002/ijc.26478. Epub 2012 Jan 11. Int J Cancer. 2012. PMID: 21989738 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous